These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 28475116)

  • 1. Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.
    Brings S; Fleming T; Freichel M; Muckenthaler MU; Herzig S; Nawroth PP
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.
    König A; Vicente Miranda H; Outeiro TF
    J Parkinsons Dis; 2018; 8(1):33-43. PubMed ID: 29480231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation.
    Ruggiero-Lopez D; Lecomte M; Moinet G; Patereau G; Lagarde M; Wiernsperger N
    Biochem Pharmacol; 1999 Dec; 58(11):1765-73. PubMed ID: 10571251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Repair from Glycation by Glyoxals by the DJ-1 Family Maillard Deglycases.
    Mihoub M; Abdallah J; Richarme G
    Adv Exp Med Biol; 2017; 1037():133-147. PubMed ID: 29147907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting advanced glycation with pharmaceutical agents: where are we now?
    Borg DJ; Forbes JM
    Glycoconj J; 2016 Aug; 33(4):653-70. PubMed ID: 27392438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibition of glycation processes.
    Beisswenger P; Ruggiero-Lopez D
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S95-103. PubMed ID: 14502106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylglyoxal and Advanced Glycation End Products in Patients with Diabetes - What We Know so Far and the Missing Links.
    Groener JB; Oikonomou D; Cheko R; Kender Z; Zemva J; Kihm L; Muckenthaler M; Peters V; Fleming T; Kopf S; Nawroth PP
    Exp Clin Endocrinol Diabetes; 2019 Sep; 127(8):497-504. PubMed ID: 28407670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New biomarkers of Maillard reaction damage to proteins.
    Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
    Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocoa melanoidins reduce the formation of dietary advanced glycation end-products in dairy mimicking system.
    Zhang H; Troise AD; Zhang H; Fogliano V
    Food Chem; 2021 May; 345():128827. PubMed ID: 33348132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridoxamine inhibits maillard reactions in diabetic rat lenses.
    Padival S; Nagaraj RH
    Ophthalmic Res; 2006; 38(5):294-302. PubMed ID: 16974131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mechanisms of Inhibition of Advanced Glycation End Products Formation through Polyphenols in Hyperglycemic Condition.
    Khangholi S; Majid FA; Berwary NJ; Ahmad F; Aziz RB
    Planta Med; 2016 Jan; 82(1-2):32-45. PubMed ID: 26550791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.
    Thornalley PJ; Langborg A; Minhas HS
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):109-16. PubMed ID: 10548540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications.
    Alouffi S; Khan MWA
    Curr Protein Pept Sci; 2020; 21(9):890-898. PubMed ID: 31660813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression.
    Lin JA; Wu CH; Lu CC; Hsia SM; Yen GC
    Mol Nutr Food Res; 2016 Aug; 60(8):1850-64. PubMed ID: 26774083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dicarbonyl derived post-translational modifications: chemistry bridging biology and aging-related disease.
    Sibbersen C; Johannsen M
    Essays Biochem; 2020 Feb; 64(1):97-110. PubMed ID: 31939602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study.
    Piazza M; Hanssen NMJ; Persson F; Scheijen JL; van de Waarenburg MPH; van Greevenbroek MMJ; Rossing P; Hovind P; Stehouwer CDA; Parving HH; Schalkwijk CG
    Diabet Med; 2021 Sep; 38(9):e14405. PubMed ID: 32961617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation endproducts in food and their effects on health.
    Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
    Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.
    Sourris KC; Watson A; Jandeleit-Dahm K
    Handb Exp Pharmacol; 2021; 264():395-423. PubMed ID: 32809100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycotoxines, carbonyl stress and relevance to diabetes and its complications.
    Turk Z
    Physiol Res; 2010; 59(2):147-156. PubMed ID: 19537931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
    Fokkens BT; Mulder DJ; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    PLoS One; 2017; 12(3):e0173379. PubMed ID: 28264049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.